Vasca

Vasca, Inc. was a medical technology company that specialized in the development of innovative vascular access solutions for patients undergoing hemodialysis. The company's flagship product, the LifeSite Hemodialysis Access System, featured an implantable valve designed to provide reliable, high-flow access while minimizing the risk of infection and stenosis. This technology was particularly aimed at patients with end-stage renal disease who were not ideal candidates for traditional arteriovenous fistulas or grafts. By improving the safety and efficiency of dialysis access, Vasca sought to enhance patient outcomes and reduce healthcare costs associated with complications. In 2006, the company was acquired by C. R. Bard to expand its portfolio of dialysis-related medical devices.